Hartman Institute for Therapeutic Organ Regeneration

Megakaryocyte TGFβ1 partitions erythropoiesis into immature progenitor/stem cells and maturing precursors.

TitleMegakaryocyte TGFβ1 partitions erythropoiesis into immature progenitor/stem cells and maturing precursors.
Publication TypeJournal Article
Year of Publication2020
AuthorsDi Giandomenico S, Kermani P, Mollé N, Yabut MMia, Abu-Zeinah G, Stephens T, Messali N, Schreiner R, Brenet F, Rafii S, Scandura JM
JournalBlood
Volume136
Issue9
Pagination1044-1054
Date Published2020 Aug 27
ISSN1528-0020
KeywordsAnimals, Apoptosis, Bone Marrow, Erythroid Precursor Cells, Erythropoiesis, Erythropoietin, Gene Knockout Techniques, Hematopoietic Stem Cells, Immunophenotyping, Megakaryocyte-Erythroid Progenitor Cells, Megakaryocytes, Mice, Mice, Inbred C57BL, Mice, Transgenic, Radiation Chimera, Recombinant Proteins, Transforming Growth Factor beta1
Abstract

<p>Erythropoietin (EPO) provides the major survival signal to maturing erythroid precursors (EPs) and is essential for terminal erythropoiesis. Nonetheless, progenitor cells can irreversibly commit to an erythroid fate well before EPO acts, risking inefficiency if these progenitors are unneeded to maintain red blood cell (RBC) counts. We identified a new modular organization of erythropoiesis and, for the first time, demonstrate that the pre-EPO module is coupled to late EPO-dependent erythropoiesis by megakaryocyte (Mk) signals. Disrupting megakaryocytic transforming growth factor β1 (Tgfb1) disorganized hematopoiesis by expanding the pre-EPO pool of progenitor cells and consequently triggering significant apoptosis of EPO-dependent EPs. Similarly, pharmacologic blockade of TGFβ signaling in normal mice boosted the pre-EPO module, leading to apoptosis of EPO-sensitive EPs. Subsequent treatment with low-dose EPO triggered robust RBC production in both models. This work reveals modular regulation of erythropoiesis and offers a new strategy for overcoming chronic anemias.</p>

DOI10.1182/blood.2019003276
Alternate JournalBlood
PubMed ID32548608
PubMed Central IDPMC7453150
Grant ListT32 CA203702 / CA / NCI NIH HHS / United States

Weill Cornell Medicine
Hartman Institute for Therapeutic Organ Regeneration
1300 York Ave, Box 136 New York, NY 10065